| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,776 |
Net Tangible Asset Backing
|
21 May 2025 8:28AM |
$2.750 |
$4.380 |
risen by
59.27%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$57 |
Mining set to mobilise at Blackjack Project in June
|
21 May 2025 8:28AM |
$0.160 |
$0.052 |
fallen by
67.50%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$151 |
FY25 results announcement
|
21 May 2025 8:27AM |
$0.835 |
$0.830 |
fallen by
0.60%
|
|
PLT - Price-sensitive ASX Announcement
Full Release
Key Points
- Plenti achieved strong growth in loan origination volumes and overall loan book size.
- There is a continued focus on technology investments to improve operational efficiency and customer experience.
- Revenue increased year-on-year, driven by higher lending volumes and improved funding structures.
- Credit performance remains robust, with stringent risk management and low arrears.
- Expansion of funding sources included new warehouse facilities and strategic partnerships.
- Product innovation remains a core strategy, particularly in automotive and renewable energy finance.
- Plenti continues to prioritize digital transformation and scalable platform development.
- The company outlines a positive outlook based on market opportunities and internal capabilities.
- Operational leverage contributed to improved cost-to-income ratios.
- Strategic objectives include further automation, customer acquisition growth, and increased market penetration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$544 |
Annual General Meeting Chair's Address
|
21 May 2025 8:26AM |
$1.210 |
$1.325 |
risen by
9.50%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$151 |
Corporate governance statement and Appendix 4G
|
21 May 2025 8:25AM |
$0.835 |
$0.830 |
fallen by
0.60%
|
|
| Magontec Limited (MGL) ORDINARY FULLY PAID |
Materials |
$14 |
Minutes of AGM held on 7 May 2025
|
21 May 2025 8:25AM |
$0.200 |
$0.245 |
risen by
22.50%
|
|
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,823 |
Update - Notification of buy-back - KCN
|
21 May 2025 8:24AM |
$1.920 |
$6.820 |
risen by
255.21%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$344 |
2025 EGM Letter to Shareholders, Notice of Meeting and Proxy
|
21 May 2025 8:24AM |
$1.370 |
$1.615 |
risen by
17.88%
|
|
| Duxton Water Limited (D2O) ORDINARY FULLY PAID |
Utilities |
- |
Update - Notification of buy-back - D2O
|
21 May 2025 8:24AM |
$1.520 |
$1.530 |
risen by
0.66%
|
|
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$151 |
FY25 annual report
|
21 May 2025 8:24AM |
$0.835 |
$0.830 |
fallen by
0.60%
|
|
| COG Financial Services Limited (COG) ORDINARY FULLY PAID |
Financials |
$344 |
Update - Proposed issue of securities - COG
|
21 May 2025 8:24AM |
$1.370 |
$1.615 |
risen by
17.88%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$3,017 |
Update - Notification of buy-back - ZIP
|
21 May 2025 8:24AM |
$2.030 |
$2.400 |
risen by
18.23%
|
|
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$348 |
Resimac Acknowledges ASIC Proceedings
|
21 May 2025 8:24AM |
$0.850 |
$0.880 |
risen by
3.53%
|
|
RMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Resimac Group Limited acknowledges ASIC's Federal Court proceedings.
- Proceedings concern responsible lending obligations regarding home loans.
- Resimac is reviewing the ASIC proceedings and will cooperate.
- The company affirms its commitment to regulatory compliance.
- Resimac will update the market on any material developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Plenti Group Limited (PLT) ORDINARY FULLY PAID |
Financials |
$151 |
Preliminary final report Appendix 4E
|
21 May 2025 8:23AM |
$0.835 |
$0.830 |
fallen by
0.60%
|
|
PLT - Price-sensitive ASX Announcement
Full Release
Key Points
- Plenti Group Limited released its Preliminary Final Report for the year ending 31 March 2024 (Appendix 4E).
- Plenti reported a 34% increase in revenue to $192.3 million and a 53% increase in loan portfolio to $2.13 billion.
- The company achieved a statutory net profit after tax (NPAT) of $6.0 million, a significant turnaround from a loss of $5.0 million in the previous year.
- The group generated a cash NPAT of $11.0 million, up from $2.7 million last year.
- Plenti’s loan originations grew by 30% to $1.5 billion, driven by growth in automotive, renewable energy, and personal lending divisions.
- Operating expenses increased by 13% to $53.7 million, mainly due to investments in technology and people to support growth.
- Credit performance remained strong, with 90+ day arrears at 46 basis points of the loan portfolio, highlighting robust credit management.
- The company reported cash and cash equivalents of $28.3 million as at 31 March 2024, with undrawn funding commitments of approximately $900 million.
- Plenti did not declare a dividend for the reporting period.
- The report includes comprehensive financial statements, notes to accounts, and commentary on the company’s strategy, outlook, and risk factors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$74 |
Urological Expert Appointed to LTR Scientific Advisory Board
|
21 May 2025 8:22AM |
$0.390 |
$0.405 |
risen by
3.85%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- LTR Pharma Ltd has appointed Professor Christopher Chapple to its Scientific Advisory Board.
- Professor Chapple is recognized as a leading expert in the field of urology.
- The appointment is intended to support the late-stage development of SPONTAN, LTR Pharma’s proprietary nasal spray formulation of sildenafil.
- SPONTAN aims to offer a fast-acting alternative for the treatment of erectile dysfunction.
- Professor Chapple’s role includes providing guidance on clinical programs, regulatory affairs, and strengthening ties with the urological community.
- The announcement underscores LTR Pharma’s commitment to advancing innovative treatments in men’s health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$65 |
Update - Notification of buy-back - M7T
|
21 May 2025 8:22AM |
$0.375 |
$0.275 |
fallen by
26.67%
|
|
| Skylark Minerals Limited (SKM) ORDINARY FULLY PAID |
Materials |
$44 |
Field Team Mobilised to Simon Project, Mt Isa
|
21 May 2025 8:22AM |
$0.180 |
$0.335 |
risen by
86.11%
|
|
SKM - Price-sensitive ASX Announcement
Full Release
Key Points
- Skylark Minerals Limited (ASX: SKM) has mobilised its field team to the Simon Project near Mt Isa, Queensland.
- The Simon Project targets copper and critical minerals exploration.
- Initial fieldwork will include geological mapping, rock chip sampling, and planning for geophysical surveys.
- The project area is in proximity to established mining operations and infrastructure.
- SKM aims to identify and advance large-scale base metal deposits.
- The exploration program is designed to improve geological understanding and support future resource definition.
- This initiative marks a significant step forward in SKM’s exploration strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalrymple Bay Infrastructure Limited (DBI) FULLY PAID ORDINARY/NOTES STAPLED SECURITIES |
Industrials |
$2,613 |
2025 Annual General Meeting
|
21 May 2025 8:22AM |
$4.090 |
$5.270 |
risen by
28.85%
|
|
| AVADA Group Limited (AVD) ORDINARY FULLY PAID |
Industrials |
$8 |
Final Director's Interest Notice JW LB
|
21 May 2025 8:22AM |
$0.245 |
$0.094 |
fallen by
61.63%
|
|
| Noxopharm Limited (NOX) ORDINARY FULLY PAID |
Health Care |
$19 |
NYR: Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.068 |
$0.063 |
fallen by
7.35%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$132 |
Notice of Ceasing to be a Substantial Holder - NOX
|
21 May 2025 8:21AM |
$0.110 |
$0.540 |
risen by
390.91%
|
|
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$396 |
Update - Notification of buy-back - CVW
|
21 May 2025 8:21AM |
$0.485 |
$0.630 |
risen by
29.90%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$151 |
Ceasing to be a substantial holder
|
21 May 2025 8:21AM |
$0.021 |
$0.042 |
risen by
100%
|
|
| Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$10 |
Proposed issue of securities - TEE
|
21 May 2025 8:21AM |
$0.066 |
$0.037 |
fallen by
43.94%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$429 |
Notification of cessation of securities - CGS
|
21 May 2025 8:21AM |
$1.340 |
$2.510 |
risen by
87.31%
|
|